Literature DB >> 24155314

Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons.

Judith P Golden1, Joseph A Demaro, Amanda Knoten, Masato Hoshi, Elizabeth Pehek, Eugene M Johnson, Robert W Gereau, Sanjay Jain.   

Abstract

The loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) and consequent depletion of striatal dopamine are known to underlie the motor deficits observed in Parkinson's disease (PD). Adaptive changes in dopaminergic terminals and in postsynaptic striatal neurons can compensate for significant losses of striatal dopamine, resulting in preservation of motor behavior. In addition, compensatory changes independent of striatal dopamine have been proposed based on PD therapies that modulate nondopaminergic circuits within the basal ganglia. We used a genetic strategy to selectively destroy dopaminergic neurons in mice during development to determine the necessity of these neurons for the maintenance of normal motor behavior in adult and aged mice. We find that loss of 90% of SNc dopaminergic neurons and consequent depletion of >95% of striatal dopamine does not result in changes in motor behavior in young-adult or aged mice as evaluated by an extensive array of motor behavior tests. Treatment of aged mutant mice with the dopamine receptor antagonist haloperidol precipitated motor behavior deficits in aged mutant mice, indicating that <5% of striatal dopamine is sufficient to maintain motor function in these mice. We also found that mutant mice exhibit an exaggerated response to l-DOPA compared with control mice, suggesting that preservation of motor function involves sensitization of striatal dopamine receptors. Our results indicate that congenital loss of dopaminergic neurons induces remarkable adaptions in the nigrostriatal system where limited amounts of dopamine in the dorsal striatum can maintain normal motor function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24155314      PMCID: PMC3807031          DOI: 10.1523/JNEUROSCI.0890-13.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

1.  Selective subregional dopamine depletions in the rat caudate-putamen following nigrostriatal lesions.

Authors:  E A Pehek; R Crock; B K Yamamoto
Journal:  Synapse       Date:  1992-04       Impact factor: 2.562

Review 2.  The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder.

Authors:  Brian K Barlow; Deborah A Cory-Slechta; Eric K Richfield; Mona Thiruchelvam
Journal:  Reprod Toxicol       Date:  2007-02-06       Impact factor: 3.143

3.  In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain.

Authors:  ZaoDung Ling; Dave A Gayle; Shang Yong Ma; Jack W Lipton; Chong Wai Tong; Jau-Shyong Hong; Paul M Carvey
Journal:  Mov Disord       Date:  2002-01       Impact factor: 10.338

4.  Systemic lipopolysaccharide plus MPTP as a model of dopamine loss and gait instability in C57Bl/6J mice.

Authors:  Stefanie L Byler; Gary W Boehm; Jonathan D Karp; Rachel A Kohman; Andrew J Tarr; Timothy Schallert; Timothy M Barth
Journal:  Behav Brain Res       Date:  2008-11-25       Impact factor: 3.332

5.  Six-hydroxydopamine induced hyperactivity: neither sex differences nor caffeine stimulation are found.

Authors:  L Erinoff; P H Kelly; M Basura; S R Snodgrass
Journal:  Pharmacol Biochem Behav       Date:  1984-05       Impact factor: 3.533

6.  Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.

Authors:  Mona Thiruchelvam; Alison McCormack; Eric K Richfield; Raymond B Baggs; A William Tank; Donato A Di Monte; Deborah A Cory-Slechta
Journal:  Eur J Neurosci       Date:  2003-08       Impact factor: 3.386

Review 7.  Is there muscular weakness in Parkinson's disease?

Authors:  Roberto Cano-de-la-Cuerda; Marta Pérez-de-Heredia; Juan Carlos Miangolarra-Page; Elena Muñoz-Hellín; Cesar Fernández-de-Las-Peñas
Journal:  Am J Phys Med Rehabil       Date:  2010-01       Impact factor: 2.159

8.  Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation.

Authors:  Z S Li; T D Pham; H Tamir; J J Chen; M D Gershon
Journal:  J Neurosci       Date:  2004-02-11       Impact factor: 6.167

Review 9.  Adenosine A2A antagonists in Parkinson's disease: what's next?

Authors:  Patrick Hickey; Mark Stacy
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

Review 10.  Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease.

Authors:  Paul M Carvey; Qin Chang; Jack W Lipton; Zaodung Ling
Journal:  Front Biosci       Date:  2003-09-01
View more
  21 in total

1.  A new mouse model to study compensatory mechanisms that support normal motor function in Parkinson's disease.

Authors:  Xiang Bai; Stacy A Hussong
Journal:  J Biochem Pharmacol Res       Date:  2014-06

2.  Adenylyl cylases 1 and 8 mediate select striatal-dependent behaviors and sensitivity to ethanol stimulation in the adolescent period following acute neonatal ethanol exposure.

Authors:  Laura L Susick; Jennifer L Lowing; Kelly E Bosse; Clara C Hildebrandt; Alexandria C Chrumka; Alana C Conti
Journal:  Behav Brain Res       Date:  2014-04-24       Impact factor: 3.332

3.  Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats.

Authors:  Shamsher Singh; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2016-11-16       Impact factor: 4.473

4.  Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model.

Authors:  Nicole K Polinski; Terina N Martinez; Alexander Gorodinsky; Ralph Gareus; Michael Sasner; Mark Herberth; Robert Switzer; Syed O Ahmad; Mali Cosden; Monika Kandebo; Robert E Drolet; Peter D Buckett; Weisong Shan; Yi Chen; Lee J Pellegrino; Gregory D Ellsworth; Leo B Dungan; Warren D Hirst; Sean W Clark; Kuldip D Dave
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

5.  An Efficient and Versatile System for Visualization and Genetic Modification of Dopaminergic Neurons in Transgenic Mice.

Authors:  Karsten Tillack; Helia Aboutalebi; Edgar R Kramer
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

6.  6-OHDA-Induced Changes in Parkinson's Disease-Related Gene Expression are not Affected by the Overexpression of PGAM5 in In Vitro Differentiated Embryonic Mesencephalic Cells.

Authors:  Tomasz Maciej Stępkowski; Iwona Wasyk; Agnieszka Grzelak; Marcin Kruszewski
Journal:  Cell Mol Neurobiol       Date:  2015-05-19       Impact factor: 5.046

Review 7.  Dissecting the role of Engrailed in adult dopaminergic neurons--Insights into Parkinson disease pathogenesis.

Authors:  Hocine Rekaik; François-Xavier Blaudin de Thé; Alain Prochiantz; Julia Fuchs; Rajiv L Joshi
Journal:  FEBS Lett       Date:  2015-10-13       Impact factor: 4.124

8.  Unaltered striatal dopamine release levels in young Parkin knockout, Pink1 knockout, DJ-1 knockout and LRRK2 R1441G transgenic mice.

Authors:  Gonzalo Sanchez; Rafael K Varaschin; Hansruedi Büeler; Paul C Marcogliese; David S Park; Louis-Eric Trudeau
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

Review 9.  Hemispheric differences in the mesostriatal dopaminergic system.

Authors:  Ilana Molochnikov; Dana Cohen
Journal:  Front Syst Neurosci       Date:  2014-06-11

10.  Soft, stretchable, fully implantable miniaturized optoelectronic systems for wireless optogenetics.

Authors:  Sung Il Park; Daniel S Brenner; Gunchul Shin; Clinton D Morgan; Bryan A Copits; Ha Uk Chung; Melanie Y Pullen; Kyung Nim Noh; Steve Davidson; Soong Ju Oh; Jangyeol Yoon; Kyung-In Jang; Vijay K Samineni; Megan Norman; Jose G Grajales-Reyes; Sherri K Vogt; Saranya S Sundaram; Kellie M Wilson; Jeong Sook Ha; Renxiao Xu; Taisong Pan; Tae-Il Kim; Yonggang Huang; Michael C Montana; Judith P Golden; Michael R Bruchas; Robert W Gereau; John A Rogers
Journal:  Nat Biotechnol       Date:  2015-11-09       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.